Cytochrome P450-based cancer gene therapy: current status

By Kan On   Kingsman Susan   Naylor Stuart  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 857-868

Informa Healthcare

Access to resources Recommend Favorite

Antibody-directed enzyme prodrug therapy (ADEPT) for cancer

By Bagshawe Kenneth D   Sharma Surinder K   Begent Richard HJ  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1777-1789

Informa Healthcare

Access to resources Recommend Favorite

Design, synthesis, and evaluation of 4-(4^′-aminobenzyl)-2-oxazolidinones as novel inhibitors of the cytochrome P-450 enzyme aromatase

By Ahmed S.   Adat S.   Murrells A.   Owen C.P.   Amanuel Y.  

Bioorganic Chemistry, Vol. 30, Iss. 5, 2002-10 ,pp. : 315-331

Academic Press

Access to resources Recommend Favorite

Cytochrome P450 2C11: Escherichia coli Expression, Purification, Functional Characterization, and Mechanism-Based Inactivation of the Enzyme

By Licad-Coles E.   He K.   Yin H.   Correia M.A.  

Archives of Biochemistry and Biophysics, Vol. 338, Iss. 1, 1997-02 ,pp. : 35-42

Elsevier

Access to resources Recommend Favorite

Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain

By Bylund J.   Zhang C.   Harder D.R.  

Biochemical and Biophysical Research Communications, Vol. 296, Iss. 3, 2002-08 ,pp. : 677-684

Elsevier

Access to resources Recommend Favorite